ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,650.70
4.28%
S&P 500
5,128.93
1.28%
Dow Jones
38,666.86
1.15%
US Dollar vs Yen
152.951
-0.06%
Brent Oil
82.78
-1.02%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Viking Therapeutics Inc (VKTX)

  7. Viking Therapeutics Inc (VKTX) ニュース

VKTX Viking Therapeutics Inc

77.29
1.53 (2.02%)
最終更新日： 04:04:20
15分遅延
名称 銘柄コード 市場 種別
Viking Therapeutics Inc VKTX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
1.53 2.02% 77.29 04:04:20
始値 安値 高値 終値 前日終値
74.40 72.88 77.68 75.76
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2505:05PRNUSViking Therapeutics Reports First Quarter 2024 Financial..
2024/4/2420:31IHMARKETNEWSU.S. Futures Display Mixed Results Amid Earnings, WTI and..
2024/4/1805:05PRNUSViking Therapeutics to Report Financial Results for First..
2024/3/2620:03PRNUSViking Therapeutics Announces Results from Phase 1 Clinical..
2024/3/0509:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0509:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0506:52EDGAR2Form 8-K - Current report
2024/3/0506:45PRNUSViking Therapeutics Announces Closing of Public Offering of..
2024/3/0206:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/2910:50PRNUSViking Therapeutics Announces Pricing of $550 Million Public..
2024/2/2807:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/2806:19PRNUSViking Therapeutics Announces Proposed Public Offering of..
2024/2/2721:04EDGAR2Form 8-K - Current report
2024/2/2721:03PRNUSViking Therapeutics Announces Positive Top-Line Results from..
2024/2/1010:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1006:01EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0909:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0909:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0906:56EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0906:33EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0807:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/0807:24EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/0806:09EDGAR2Form 8-K - Current report
2024/2/0806:05PRNUSViking Therapeutics Reports Fourth Quarter and Year-End 2023..
2024/2/0110:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0107:32EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0106:05PRNUSViking Therapeutics to Report Financial Results for Fourth..
2024/1/3111:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3106:23EDGAR2Form 144 - Report of proposed sale of securities
2024/1/2010:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2006:36EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0511:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0511:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0511:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1406:02PRNUSViking Therapeutics Presents New Data from Phase 2b VOYAGE..
2023/11/0305:03PRNUSViking Therapeutics to Participate at Upcoming Investor..
2023/10/2606:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/2605:24EDGAR2Form 8-K - Current report
2023/10/2605:05PRNUSViking Therapeutics Reports Third Quarter 2023 Financial..
2023/10/2320:05PRNUSViking Therapeutics Announces Completion of Enrollment in..
2023/10/1905:05PRNUSViking Therapeutics to Report Financial Results for Third..
2023/10/1822:06IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
2023/10/1822:03IHMARKETNEWSWednesday’s Wall Street Highlights: ASML, Nvidia, United..
2023/10/1805:05PRNUSViking Therapeutics Presents New Data from Phase 1 Clinical..
2023/10/1105:05PRNUSViking Therapeutics to Highlight Data from Phase 1 Clinical..
2023/9/0805:05PRNUSViking Therapeutics to Participate at Upcoming Investor..
2023/9/0620:03PRNUSViking Therapeutics Announces Initiation of Phase 2 VENTURE..
2023/7/2706:26EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2023/7/2705:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/7/2705:23EDGAR2Form 8-K - Current report

最近閲覧した銘柄

NASDAQ
VKTX
Viking Therapeutics
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有